Betatinib

倍他替尼

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameBetatinib
Drug Alias NameTL-512
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Teligene LtdAspedia Llc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJinghua Pharmaceutical Group Co LtdSuzhou Teligene Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A